BRIMONIDINE TARTRATE Gel (Mirvaso®) - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

BRIMONIDINE TARTRATE Gel (Mirvaso®)

Last Updated: 23 July 2018

Body System: Skin

Green

The Pan Mersey Area Prescribing Committee recommends the restricted prescribing of BRIMONIDINE TARTRATE gel (Mirvaso®) for use in adults with moderate to severe facial erythema associated with rosacea, following dermatology specialist initiation, and continued only if the criteria below are met.